According to Mark Cuban, NIH research played a role in the approval of every drug by the FDA from 2010 to 2016. This highlights the critical support NIH provides in drug development, which may affect pharmaceutical investment strategies. Traders should consider the importance of NIH-funded research in evaluating pharma stocks.